Connect
MJA
MJA

Pharmaceutical Preparations

Editorials

A life-cycle approach to monitoring benefits and harms of medicines

Emily Banks and Sallie-Anne Pearson

Med J Aust 2012; 197 (6): 313-314

Letters

Pharmacoepidemiology of testosterone prescribing in Australia, 1992–2010

Stephen P Fitzgerald

Med J Aust 2012; 197 (6): 329-330

Letters

Pharmacoepidemiology of testosterone prescribing in Australia, 1992–2010

Peter M Herriot

Med J Aust 2012; 197 (6): 330

Letters

The Jarisch–Herxheimer reaction in a patient with leptospirosis: a foreseeable problem in managing spirochaete infections

Ryan Markham, Andrew Slack and John Gerrard

Med J Aust 2012; 197 (5): 276-277

Letters

A screening program to detect aminoglycoside- induced ototoxicity

Maryam Teimoori, Gina Mistry, Carmela Corallo and Allen C Cheng

Med J Aust 2012; 197 (4): 216-217

Editorials

Drug treatment for melanoma: progress, but who pays?

Richard F Kefford

Med J Aust 2012; 197 (4): 198-199 Free

Perspectives

Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency

Wendy L Lipworth, Ken Ho, Ian H Kerridge and Richard O Day

Med J Aust 2012; 197 (4): 204-205 Free

Letters

Is the non-medical use of prescription stimulants a problem in Australia?

Jayne C Lucke and Wayne D Hall

Med J Aust 2012; 197 (3): 145

Editorials

Gentamicin and ototoxicity: why this drug is still in use

John D Turnidge and John A Waterston

Med J Aust 2012; 196 (11): 665-666

Research

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia

Margaret E Hellard, Rebecca Jenkinson, Peter Higgs, Mark A Stoové, Rachel Sacks-Davis, Judy Gold, Matthew Hickman, Peter Vickerman and Natasha K Martin

Med J Aust 2012; 196 (10): 638-641 Free

Perspectives

Disease mongering and low testosterone in men: the tale of two regulatory failures

Agnes I Vitry and Barbara Mintzes

Med J Aust 2012; 196 (10): 619-621

Clinical focus

The changing therapeutic landscape for hepatitis C

Gregory J Dore

Med J Aust 2012; 196 (10): 629-632 Free

Letters

Tertiary education institutions should not offer pseudoscientific medical courses

Jeffery D Hughes and Liesl A Blott

Med J Aust 2012; 196 (9): 566

Editorials

Avoiding adverse events with dabigatran by careful selection of eligible patients

Ross I Baker, Paul Harper and Claire McLintock

Med J Aust 2012; 196 (7): 431-432

Editorials

New medicines — urgent need to assess outcomes in special groups

Jennifer H Martin and Michael D Coory

Med J Aust 2012; 196 (7): 433

Research

Eligibility for medical thromboprophylaxis based on risk-factor weights, and clinical thrombotic event rates

J Alasdair Millar, Joanne E Lett, Leonard J Bagley and Ian K Densie

Med J Aust 2012; 196 (7): 457-461 Free

Editorials

Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda

Wendy L Lipworth, Ian Kerridge and Richard O Day

Med J Aust 2012; 196 (6): 374-375

Letters

Exploring melatonin prescribing among customers of compounding pharmacies in Australia

Jane Nikles, Victor Lo, Jennifer A Giam and Bandana Saini

Med J Aust 2012; 196 (6): 384-385

Ethics and law

Challenges to Australia’s national health policy from trade and investment agreements

Deborah H Gleeson, Kyla S Tienhaara and Thomas A Faunce

Med J Aust 2012; 196 (5): 354-356 Free

Perspectives

Does antibiotic use in farmed animals pose a risk to human health? — No

Stephen W Page

Med J Aust 2012; 196 (5): 303

Letters

Medication to prevent breast cancer — too much to swallow?

Jerry R Greenfield and Ann I McCormack

Med J Aust 2012; 196 (5): 314

Perspectives

Does antibiotic use in farmed animals pose a risk to human health? – Yes

Peter J Collignon

Med J Aust 2012; 196 (5): 302

Letters

A Pandora’s box: sustainable pharmaceutical supply

Robert Pearce, Simon Quilty, Jacqueline Kewley and Lisa M Harris

Med J Aust 2012; 196 (3): 170-171

Letters

A to X: the problem of categorisation of drugs in pregnancy — an Australian perspective

Ronald P Batagol

Med J Aust 2012; 196 (3): 172

Letters

A to X: the problem of categorisation of drugs in pregnancy — an Australian perspective

Adam P Morton

Med J Aust 2012; 196 (3): 172